Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 19/20 | 0.37 |
| ▸ | ITGA2B | P08514 | 19/20 | 0.37 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7401924 | 0.85 | ITGB3 (0.44) | ITGB3ITGA2B | |
| SCHEMBL7399991 | 0.85 | ITGB3 (0.38) | ITGB3ITGA2B | |
| SCHEMBL7982063 | 0.81 | ITGB3 (0.42) | ITGB3ITGA2BSMPD1 | |
| SCHEMBL7400722 | 0.74 | SYK (0.47) | ITGB3ITGA2B | |
| Iodide SCHEMBL7403599 | 0.74 | ITGB3 (0.49) | ITGB3ITGA2B | |
| SCHEMBL8549170 | 0.74 | ITGB3 (0.36) | ITGB3ITGA2B | |
| SCHEMBL8644585 | 0.73 | ALDH1A1 (0.33) | SMPD1 | |
| SCHEMBL8644539 | 0.72 | ALDH1A1 (0.33) | SMPD1 | |
| SCHEMBL7396418 | 0.71 | SMPD1 (0.39) | ITGB3ITGA2BSMPD1 | |
| SCHEMBL6111432 | 0.71 | ITGB3 (0.46) | ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0828737-A1 | ISOXAZOLINE AND ISOXAZOLE DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-03-18 | — | — | EP | claimed |
| WO-1996037492-A1 | ISOXAZOLINE AND ISOXAZOLE DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-11-28 | — | — | WO | claimed |
| EP-0828737-A1 | ISOXAZOLINE AND ISOXAZOLE DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996037492-A1 | ISOXAZOLINE AND ISOXAZOLE DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-11-28 | — | — | WO | disclosed |